BACKGROUND AND PURPOSE: Organized systems of care have the potential to improve acute stroke care delivery. The current report describes the experience of implementing a county-wide system of spoke-and-hub stroke neurology receiving centers (SNRC) that incorporated several comprehensive stroke center recommendations. METHODS: Observational study of patients with suspected stroke of <5 hours duration transported by emergency medical system personnel to an SNRC during the first year of this system. RESULTS: A total of 1360 patients with suspected stroke were evaluated at 9 hub SNRC, of which 553 (40.7%) had a discharge diagnosis of ischemic stroke. Of these 553, intravenous tissue-type plasminogen activator was administered to 110 patients (19.9% of ischemic strokes). Care at the 6 neurointerventional-ready SNRC was a major focus in which 25.1% (99/395) of the patients with ischemic stroke received acute intravenous or intra-arterial reperfusion therapy, and in which provision of such therapies was less common with milder stroke, older age, and Hispanic origin. The door-to-needle time for intravenous tissue-type plasminogen activator met the <60-minute target in only 25% of patients and was 37% longer (P=0.0001) when SNRC were neurointerventional-ready. CONCLUSIONS: A stroke system that incorporates features of comprehensive stroke centers can be effectively implemented with substantial rates of acute reperfusion therapy administration. Experiences potentially useful to broader implementation of comprehensive stroke centers are considered.
BACKGROUND AND PURPOSE: Organized systems of care have the potential to improve acute stroke care delivery. The current report describes the experience of implementing a county-wide system of spoke-and-hub stroke neurology receiving centers (SNRC) that incorporated several comprehensive stroke center recommendations. METHODS: Observational study of patients with suspected stroke of <5 hours duration transported by emergency medical system personnel to an SNRC during the first year of this system. RESULTS: A total of 1360 patients with suspected stroke were evaluated at 9 hub SNRC, of which 553 (40.7%) had a discharge diagnosis of ischemic stroke. Of these 553, intravenous tissue-type plasminogen activator was administered to 110 patients (19.9% of ischemic strokes). Care at the 6 neurointerventional-ready SNRC was a major focus in which 25.1% (99/395) of the patients with ischemic stroke received acute intravenous or intra-arterial reperfusion therapy, and in which provision of such therapies was less common with milder stroke, older age, and Hispanic origin. The door-to-needle time for intravenous tissue-type plasminogen activator met the <60-minute target in only 25% of patients and was 37% longer (P=0.0001) when SNRC were neurointerventional-ready. CONCLUSIONS:A stroke system that incorporates features of comprehensive stroke centers can be effectively implemented with substantial rates of acute reperfusion therapy administration. Experiences potentially useful to broader implementation of comprehensive stroke centers are considered.
Authors: Mark J Alberts; Richard E Latchaw; Warren R Selman; Timothy Shephard; Mark N Hadley; Lawrence M Brass; Walter Koroshetz; John R Marler; John Booss; Richard D Zorowitz; Janet B Croft; Ellen Magnis; Diane Mulligan; Andrew Jagoda; Robert O'Connor; C Michael Cawley; J J Connors; Jean A Rose-DeRenzy; Marian Emr; Margo Warren; Michael D Walker Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: Amie W Hsia; Dorothy F Edwards; Lewis B Morgenstern; Jeffrey J Wing; Nina C Brown; Regina Coles; Sarah Loftin; Andrea Wein; Sara S Koslosky; Sabiha Fatima; Brisa N Sánchez; Ali Fokar; M Chris Gibbons; Nawar Shara; Annapurni Jayam-Trouth; Chelsea S Kidwell Journal: Stroke Date: 2011-06-30 Impact factor: 7.914
Authors: Dana Leifer; Dawn M Bravata; J J Buddy Connors; Judith A Hinchey; Edward C Jauch; S Claiborne Johnston; Richard Latchaw; William Likosky; Christopher Ogilvy; Adnan I Qureshi; Debbie Summers; Gene Y Sung; Linda S Williams; Richard Zorowitz Journal: Stroke Date: 2011-01-13 Impact factor: 7.914
Authors: Ying Xian; Robert G Holloway; Paul S Chan; Katia Noyes; Manish N Shah; Henry H Ting; Andre R Chappel; Eric D Peterson; Bruce Friedman Journal: JAMA Date: 2011-01-26 Impact factor: 56.272
Authors: Gregg C Fonarow; Eric E Smith; Jeffrey L Saver; Mathew J Reeves; Deepak L Bhatt; Maria V Grau-Sepulveda; DaiWai M Olson; Adrian F Hernandez; Eric D Peterson; Lee H Schwamm Journal: Circulation Date: 2011-02-10 Impact factor: 29.690
Authors: M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker Journal: JAMA Date: 2000-06-21 Impact factor: 56.272
Authors: D Stradling; W Yu; M L Langdorf; F Tsai; V Kostanian; A N Hasso; S J Welbourne; Y Schooley; M J Fisher; S C Cramer Journal: Neurology Date: 2007-02-06 Impact factor: 9.910
Authors: Radoslav I Raychev; Dana Stradling; Nirav Patel; Joey R Gee; David A Lombardi; Johnson L Moon; David M Brown; Mayank Pathak; Wengui Yu; Samuel J Stratton; Steven C Cramer Journal: Stroke Date: 2018-04-06 Impact factor: 7.914
Authors: Maarten M H Lahr; Gert-Jan Luijckx; Patrick C A J Vroomen; Durk-Jouke van der Zee; Erik Buskens Journal: J Neurol Date: 2012-08-23 Impact factor: 4.849
Authors: Michael T Mullen; Suzanne Judd; Virginia J Howard; Scott E Kasner; Charles C Branas; Karen C Albright; J David Rhodes; Dawn O Kleindorfer; Brendan G Carr Journal: Stroke Date: 2013-05-02 Impact factor: 7.914
Authors: Daniel T Lackland; Edward J Roccella; Anne F Deutsch; Myriam Fornage; Mary G George; George Howard; Brett M Kissela; Steven J Kittner; Judith H Lichtman; Lynda D Lisabeth; Lee H Schwamm; Eric E Smith; Amytis Towfighi Journal: Stroke Date: 2013-12-05 Impact factor: 7.914
Authors: F Chollet; S C Cramer; C Stinear; L J Kappelle; J C Baron; C Weiller; P Azouvi; M Hommel; U Sabatini; T Moulin; J Tardy; M Valenti; S Montgomery; H Adams Journal: J Neurol Date: 2013-11-13 Impact factor: 4.849
Authors: Christopher I Price; Victoria Rae; Jay Duckett; Ruth Wood; Joanne Gray; Peter McMeekin; Helen Rodgers; Karen Portas; Gary A Ford Journal: PLoS One Date: 2013-10-08 Impact factor: 3.240